Medivation (MDVN) Tops Q4 EPS by 5c, Offers Guidance

Medivation (NASDAQ: MDVN) reported Q4 EPS of $0.29, $0.05 better than the analyst estimate of $0.24. Revenue for the quarter came in at $377.75 million versus the consensus estimate of $371.94 million.

GUIDANCE:

Medivation sees FY2016 EPS of $1.30-$1.40, versus the consensus of $1.35.

  

U.S. net sales of XTANDI                        $1.425 to $1.525 billion(1)

Non-GAAP collaboration revenue                    $900 to $970 million(2)

Non-GAAP operating expenses                       $555 to $600 million(3)

  Non-GAAP R&D expenses                           $280 to $300 million(4)

  Non-GAAP SG&A expenses                          $275 to $300 million(5)

Non-GAAP tax rate(6)                                    35.5% - 36%

Non-GAAP diluted earnings per share                    $1.30 - $1.40

For earnings history and earnings-related data on Medivation (MDVN) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• BofA lists top 5 themes driving next $1tn in incremental semi sales
• CVG to join Russell 2000 and Russell 3000 indexes June 26